The injection of these immunosuppressive microparticles together with PLGA microparticles that encapsulated the epitope insulin B9–23 significantly delayed the onset of T1D in NOD (non-obese diabetic) mice, a mouse model for the spontaneous development of T1D. The gene discussed is INS; the disease is type 1 diabetes mellitus.